Journal IJCRT UGC-CARE, UGCCARE( ISSN: 2320-2882 ) | UGC Approved Journal | UGC Journal | UGC CARE Journal | UGC-CARE list, New UGC-CARE Reference List, UGC CARE Journals, International Peer Reviewed Journal and Refereed Journal, ugc approved journal, UGC CARE, UGC CARE list, UGC CARE list of Journal, UGCCARE, care journal list, UGC-CARE list, New UGC-CARE Reference List, New ugc care journal list, Research Journal, Research Journal Publication, Research Paper, Low cost research journal, Free of cost paper publication in Research Journal, High impact factor journal, Journal, Research paper journal, UGC CARE journal, UGC CARE Journals, ugc care list of journal, ugc approved list, ugc approved list of journal, Follow ugc approved journal, UGC CARE Journal, ugc approved list of journal, ugc care journal, UGC CARE list, UGC-CARE, care journal, UGC-CARE list, Journal publication, ISSN approved, Research journal, research paper, research paper publication, research journal publication, high impact factor, free publication, index journal, publish paper, publish Research paper, low cost publication, ugc approved journal, UGC CARE, ugc approved list of journal, ugc care journal, UGC CARE list, UGCCARE, care journal, UGC-CARE list, New UGC-CARE Reference List, UGC CARE Journals, ugc care list of journal, ugc care list 2020, ugc care approved journal, ugc care list 2020, new ugc approved journal in 2020, ugc care list 2021, ugc approved journal in 2021, Scopus, web of Science.
How start New Journal & software Book & Thesis Publications
Submit Your Paper
Login to Author Home
Communication Guidelines

WhatsApp Contact
Click Here

  Published Paper Details:

  Paper Title

A REVIEW: COVID-19 REPURPOSED AND AUTHORIZED DRUGS AND ITS SIDE EFFECTS.

  Authors

  K.SAI PREETHI,  S D SHALINI,  J.V.C.SHARMA,  B. Manasa,  CH.M.MAHESHWARI

  Keywords

covid-19, SARS-COV-2, Antivirals, Repurposing drugs, Emergency use approval, Vaccine development.

  Abstract


Coronavirus disease 19 (covid-19) is an infectious disease caused by the novel SARS-CoV-2 (Severe Acute Respiratory Syndrome Corona virus-2) has emerged as a worldwide threat in December-2019 and then spread rapidly. Scientists and Clinicians are attempting to find antivirals specific to the virus, vaccine development for a novel virus is a challenging effort for them which may take several years to discover. Design and repurpose of existing drugs have been studied by researchers for the approval of other conditions which are effective against covid-19. Repurposed drugs may not be highly potent, as they are not developed specifically to this particular virus. Finally, two vaccines have been granted for emergency use approval in India by the government. The main purpose of this study on covid-19 vaccine development, repurposed drugs and approved drugs- its side effects, advancements and challenges during vaccine development. By this we can understand the vaccine development process and its current authorized approved drugs.

  IJCRT's Publication Details

  Unique Identification Number - IJCRT2102135

  Paper ID - 203072

  Page Number(s) - 1063-1067

  Pubished in - Volume 9 | Issue 2 | February 2021

  DOI (Digital Object Identifier) -   

  Publisher Name - IJCRT | www.ijcrt.org | ISSN : 2320-2882

  E-ISSN Number - 2320-2882

  Cite this article

  K.SAI PREETHI,  S D SHALINI,  J.V.C.SHARMA,  B. Manasa,  CH.M.MAHESHWARI,   "A REVIEW: COVID-19 REPURPOSED AND AUTHORIZED DRUGS AND ITS SIDE EFFECTS.", International Journal of Creative Research Thoughts (IJCRT), ISSN:2320-2882, Volume.9, Issue 2, pp.1063-1067, February 2021, Available at :http://www.ijcrt.org/papers/IJCRT2102135.pdf

  Share this article

  Article Preview

  Indexing Partners

indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
Call For Paper May 2024
Indexing Partner
ISSN and 7.97 Impact Factor Details


ISSN
ISSN
ISSN: 2320-2882
Impact Factor: 7.97 and ISSN APPROVED
Journal Starting Year (ESTD) : 2013
ISSN
ISSN and 7.97 Impact Factor Details


ISSN
ISSN
ISSN: 2320-2882
Impact Factor: 7.97 and ISSN APPROVED
Journal Starting Year (ESTD) : 2013
ISSN
DOI Details

Providing A Free digital object identifier by DOI.one How to get DOI?
For Reviewer /Referral (RMS) Earn 500 per paper
Our Social Link
Open Access
This material is Open Knowledge
This material is Open Data
This material is Open Content
Indexing Partner

Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 7.97 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer